Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 EP1445 | DOI: 10.1530/endoabs.110.EP1445

1Farhat Hached University Hospital, ENT Department, Sousse, Tunisia; 2Farhat Hached Hospital, Department of ENT and Head and Neck Surgery, Sousse, Tunisia; 3Farhat Hached Hospital, Department of Endocrinology, Sousse, Tunisia.


JOINT680

Objective: To analyze the epidemiological and clinical features of children who underwent thyroid surgery for Grave’s disease at our departmet and to evaluate the indications and outcomes of surgical treatment.

Materials and Methods: This retrospective study includes five pediatric cases of thyroid surgery performed between 2010 and 2022 for Grave’s disease.

Results: The mean age was 16.8 years (10-17 years), and all patients were female. The average time from diagnosis to surgery was 20.3 months. At diagnosis, 60% of patients had multinodular goiters, while 40% had diffuse and homogeneous goiters. Median FT4 and TSH levels were 12.8 pmol/land 0.05 mU/l, respectively. Surgical indications included thyroid nodules (60%, with compression in one case), resistance to medical treatment (20%), and severe ophthalmopathy (20%). Total thyroidectomy was performed in all cases, with no malignancy detected. Postoperative complications were minimal, with only one case of transient hypocalcemia.

Conclusion: Total thyroidectomy is a safe and effective treatment for pediatric Grave’s disease, particularly in cases of treatment resistance or severe manifestations. When performed by experienced surgeons, it provides definitive management with a low risk of complications.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches